Theriva Biologics Inc. (TOVX) is a clinical-stage biotechnology firm based in Rockville, Maryland, focused on developing innovative therapies for diseases with significant unmet medical needs. The company leverages its proprietary technologies to create targeted biologics aimed at improving patient outcomes. With a robust pipeline and a dedicated team of experts, Theriva is positioned to make substantial contributions to therapeutic areas that require novel treatment options.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD, UNITED STATES, 20850

December

$3.99 Million

-$26.3 Million

0.0

-4.22

$0.00

0.0%

0.655